Contineum Therapeutics, Inc. CTNM
Set alert
9.39 USD +0.06 +0.64%
At close · Oct 30
9.39 0.00 0.00%
After hours · Oct 30, 4:26 PM ET
8.94 Day range 9.58
6.73 52-week range 17.79
- YTD
- -17.85%
- 1 year
- -10.91%
- Open
- 9.14
- Prev close
- 9.33
- Mkt cap
- 353.26M
- Vol
- 294.54K
- Avg vol
- 834.36K
- EPS
- -1.73
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.94
- High
- 9.58
- Forward P/E
- -7.68
- Beta
- 0.00
- Short ratio
- 13.66
- Inst. own
- 72.39%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 5, 2025
- 50-d avg
- 15.77
- 200-d avg
- 17.15
- 1y target
- 29.25
Ownership
Held by insiders 6.19%
Held by institutions 72.39%
Float held by institutions 77.17%
Institutions 78
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Johnson & Johnson | 10.39% | 1,979,173 | 27.99M | Sep 29, 2024 |
| Suvretta Capital Management, LLC | 9.03% | 1,720,000 | 24.32M | Sep 29, 2024 |
| Perceptive Advisors Llc | 7.96% | 1,516,668 | 21.45M | Sep 29, 2024 |
| Franklin Resources, Inc. | 7.60% | 1,447,550 | 20.47M | Sep 29, 2024 |
| Versant Venture Management, LLC | 4.82% | 918,163 | 12.98M | Sep 29, 2024 |
| Sectoral Asset Management, Inc. | 4.20% | 800,887 | 11.32M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Franklin Strategic Series-Franklin Biotechnology Discove | 2.69% | 512,025 | 7.24M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.57% | 299,583 | 4.24M | Sep 29, 2024 |
| Fidelity Advisor Biotechnology Fund | 1.39% | 264,800 | 3.74M | Oct 30, 2024 |
| Fidelity Select Portfolios - Health Care | 1.05% | 200,000 | 2.83M | Oct 30, 2024 |
| iShares Russell 2000 ETF | 0.75% | 142,871 | 2.02M | Oct 30, 2024 |
| Fidelity Advisor Health Care Fund | 0.67% | 128,000 | 1.81M | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| HUHN STEPHEN L | Officer | Conversion of Exercise of derivative security | Aug 12, 2024 | 12,800 |
| LORRAIN DANIEL S. PH.D. | Officer | Sale | Nov 24, 2024 | 172,460 |
| VERSANT VENTURE CAPITAL VI, L.P. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Apr 8, 2024 | 0 |
Held by funds
64 US ETFs and mutual funds hold CTNM · largest positions